Afuco™ Anti-Human CCR5 ADCC Therapeutic Antibody (HGS004), ADCC Enhanced
Anti-CCR5 ADCC Enhanced Antibody (HGS004) is an ADCC enhanced antibody produced by our Afuco™ platform. HGS004 is a human immunoglobulin (Ig) G4 monoclonal antibody against CCR5. HGS004 binds to and inhibits the activity of the CCR5 receptor on the cell surface. HIV uses both the CCR5 and the CD4 receptors to gain entry to the cell, but CCR5 is the primary receptor enabling HIV transmission and replication from the early stages of infection through to progression to AIDS.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-097CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CCR5 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |